{
  "report_rows": [
    {
      "kpi": "Q2 2026 Revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.505B vs. cons $1.50B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 Non-GAAP EPS",
      "prediction": "MISS",
      "answer": "pred ~$4.28 vs. cons $4.36",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 Adjusted EBITDA Margin",
      "prediction": "MISS",
      "answer": "pred ~20.7% vs. cons 21.2%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 Non-GAAP EPS Guidance",
      "prediction": "LOWER",
      "answer": "guide ~$18.10-$18.40 (midpoint $18.25) vs. cons $18.55 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 Adjusted EBITDA Margin Guidance",
      "prediction": "LOWER",
      "answer": "guide ~21.5%-21.8% vs. cons 22.0% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "H2 2026 Memory/DRAM Cost & Supply Commentary",
      "prediction": "LOWER",
      "answer": "guide ~implies incremental ~1-1.5pt unmitigated margin drag into H2 vs. cons assumption of full offset (H2 2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -4.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -6.5,
  "day5_path": "FADE",
  "day5_rationale": "Stock priced in a lot of good news (17-18% YTD, near 52-week highs, sell-side targets marching to $330+) heading into a print where consensus sits at the top of management's own Q2 guide. Since the May Q1 call, spot DRAM/NAND contract prices surged ~60% in Q2 - materially worse than the 2pt headwind management said it could fully offset via pricing/supplier co-planning - creating real risk that the EBITDA margin/EPS beat/mitigation narrative cracks this quarter. Even if headline EPS is roughly in line, the read-through to H2 (where management previously assured 'no indication our second-half allocation would be any less than first half') is the more important driver: any signal that memory cost inflation is outrunning mitigation forces sell-side to trim FY26/FY27 EPS and margin estimates in the days after the print, producing a fade rather than follow-through, especially given how extended the stock already is into the print (elevated bar + rich valuation = asymmetric downside on anything short of a clean beat-and-raise).",
  "day5_confidence": "MEDIUM"
}